Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Other Accumulated Expenses (2011 - 2025)

Talphera (TLPH) posted Other Accumulated Expenses of $34000.0 for Q4 2025, down 88.28% on a QoQ basis from $290000.0 in Q4 2024, and down 88.28% year-over-year from $290000.0 in Q4 2024.

Analysis

Talphera (TLPH) Other Accumulated Expenses (2011 - 2025) Analysis & Trends

Talphera has reported Other Accumulated Expenses for 13 years, with the latest figure at $34000.0 in Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 88.28% year-over-year to $34000.0 in Q4 2025; TTM through Dec 2025 was $34000.0, a 88.28% decrease from a year earlier, with the FY2025 full-year figure at $34000.0, down 88.28% from the prior year.
  • Other Accumulated Expenses was $34000.0 for Q4 2025 at Talphera, down from $290000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $1.2 million in Q4 2021, with the low at $34000.0 in Q4 2025.
  • Average Other Accumulated Expenses over 5 years is $430400.0, with a median of $319000.0 recorded in 2023.
  • The sharpest annual moves came in 2021 and 2025: Other Accumulated Expenses soared 39.14% in 2021, then plunged 88.28% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $1.2 million in 2021, then tumbled by 70.58% to $343000.0 in 2022, then dropped by 7.0% to $319000.0 in 2023, then fell by 9.09% to $290000.0 in 2024, then slumped by 88.28% to $34000.0 in 2025.
  • The last three Other Accumulated Expenses figures came in at $34000.0 (Q4 2025), $290000.0 (Q4 2024), and $319000.0 (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Talphera 92.90 Mn 92.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 34,000.00
Dec 31, 2024 290,000.00
Dec 31, 2023 319,000.00
Dec 31, 2022 343,000.00
Dec 31, 2021 1.17 Mn
Dec 31, 2020 838,000.00
Dec 31, 2019 980,000.00
Dec 31, 2018 695,000.00
Dec 31, 2017 842,000.00
Dec 31, 2016 821,000.00
Dec 31, 2015 808,000.00
Dec 31, 2014 615,000.00
Sep 30, 2011 103,000.00
Jun 30, 2011 151,000.00